Colombo T - Search Results

1

IDN5109, a taxane with oral bioavailability and potent antitumor activity.

Nicoletti MI, Colombo T, Rossi C, Monardo C, Stura S, Zucchetti M, Riva A, Morazzoni P, Donati MB, Bombardelli E, D'Incalci M, Giavazzi R. Nicoletti MI, et al. Among authors: colombo t. Cancer Res. 2000 Feb 15;60(4):842-6. Cancer Res. 2000. PMID: 10706091

2

High-performance liquid chromatographic assay for the determination of the novel taxane derivative IDN5109 in mouse plasma.

Colombo T, Frapolli R, Bombardelli E, Morazzoni P, Riva A, D'Incalci M, Zucchetti M. Colombo T, et al. J Chromatogr B Biomed Sci Appl. 1999 Dec 24;736(1-2):135-41. doi: 10.1016/s0378-4347(99)00450-8. J Chromatogr B Biomed Sci Appl. 1999. PMID: 10676993

3

Oral efficacy and bioavailability of a novel taxane.

Polizzi D, Pratesi G, Monestiroli S, Tortoreto M, Zunino F, Bombardelli E, Riva A, Morazzoni P, Colombo T, D'Incalci M, Zucchetti M. Polizzi D, et al. Among authors: colombo t. Clin Cancer Res. 2000 May;6(5):2070-4. Clin Cancer Res. 2000. PMID: 10815934

4

The combination of the tyrosine kinase receptor inhibitor SU6668 with paclitaxel affects ascites formation and tumor spread in ovarian carcinoma xenografts growing orthotopically.

Garofalo A, Naumova E, Manenti L, Ghilardi C, Ghisleni G, Caniatti M, Colombo T, Cherrington JM, Scanziani E, Nicoletti MI, Giavazzi R. Garofalo A, et al. Among authors: colombo t. Clin Cancer Res. 2003 Aug 15;9(9):3476-85. Clin Cancer Res. 2003. PMID: 12960140

5

Changes in doxorubicin distribution and toxicity in mice pretreated with the cyclosporin analogue SDZ PSC 833.

Gonzalez O, Colombo T, De Fusco M, Imperatori L, Zucchetti M, D'Incalci M. Gonzalez O, et al. Among authors: colombo t. Cancer Chemother Pharmacol. 1995;36(4):335-40. doi: 10.1007/BF00689051. Cancer Chemother Pharmacol. 1995. PMID: 7628053

6

Cyclosporin A markedly changes the distribution of doxorubicin in mice and rats.

Colombo T, Zucchetti M, D'Incalci M. Colombo T, et al. J Pharmacol Exp Ther. 1994 Apr;269(1):22-7. J Pharmacol Exp Ther. 1994. PMID: 8169829

7

Distribution and activity of doxorubicin combined with SDZ PSC 833 in mice with P388 and P388/DOX leukaemia.

Colombo T, Gonzalez Paz O, D'Incalci M. Colombo T, et al. Br J Cancer. 1996 Apr;73(7):866-71. doi: 10.1038/bjc.1996.154. Br J Cancer. 1996. PMID: 8611397 Free PMC article.

8

Paclitaxel induces significant changes in epidoxorubicin distribution in mice.

Colombo T, Gonzalez Paz O, Zucchetti M, Maneo A, Sessa C, Goldhirsch A, D'Incalci M. Colombo T, et al. Ann Oncol. 1996 Oct;7(8):801-5. doi: 10.1093/oxfordjournals.annonc.a010758. Ann Oncol. 1996. PMID: 8922193 Free article.

9

Taxoids in combination with anthracyclines and other agents: pharmacokinetic considerations.

D'Incalci M, Schüller J, Colombo T, Zucchetti M, Riva A. D'Incalci M, et al. Among authors: colombo t. Semin Oncol. 1998 Dec;25(6 Suppl 13):16-20. Semin Oncol. 1998. PMID: 9865687

10

Pharmacokinetic interactions of paclitaxel, docetaxel and their vehicles with doxorubicin.

Colombo T, Parisi I, Zucchetti M, Sessa C, Goldhirsch A, D'Incalci M. Colombo T, et al. Ann Oncol. 1999 Apr;10(4):391-5. doi: 10.1023/a:1008309916974. Ann Oncol. 1999. PMID: 10370780 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

512 results

Search Page

Filters